Van Eck Associates Corp Pacific Biosciences Of California, Inc. Transaction History

Van Eck Associates Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$3.52 - $9.59 $1,781 - $4,852	506 Added 11.47%	4,916 $18,000
Q4 2023 Feb 05, 2024	BUY	$5.97 - $10.36 $5,474 - $9,500	917 Added 26.25%	4,410 $43,000
Q3 2023 Nov 08, 2023	BUY	$8.23 - $13.93 $3,078 - $5,209	374 Added 11.99%	3,493 $29,000
Q2 2023 Aug 03, 2023	BUY	$9.97 - $14.05 $3,499 - $4,931	351 Added 12.68%	3,119 $41,000
Q1 2023 May 03, 2023	BUY	$7.94 - $12.02 $2,405 - $3,642	303 Added 12.29%	2,768 $32,000
Q4 2022 Feb 08, 2023	BUY	$5.67 - $11.2 $3,889 - $7,683	686 Added 38.56%	2,465 $20,000
Q3 2022 Oct 27, 2022	BUY	$3.93 - $8.57 $6,991 - $15,246	1,779 New	1,779 $10,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

Stay updated on Van Eck Associates Corp with notifications on news.